bretylium has been researched along with Coronary Heart Disease in 2 studies
bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregorini, L | 1 |
| Fajadet, J | 1 |
| Robert, G | 1 |
| Cassagneau, B | 1 |
| Bernis, M | 1 |
| Marco, J | 1 |
| Coker, SJ | 1 |
2 other studies available for bretylium and Coronary Heart Disease
| Article | Year |
|---|---|
Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
Topics: Angioplasty, Balloon, Coronary; Bretylium Compounds; Coronary Angiography; Coronary Disease; Coronar | 1994 |
Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Coronary Disease; Coronary Vessels; | 1989 |